BLISSGVSNSEBliss GVS Pharma Limited· PharmaceuticalsMinimalNeutral
Announced Tue, 2 Jun · 11:24 IST

SBI Capital Markets Limited has Submitted to the Exchange a copy of newspaper publication regarding the Detailed Public Statement in connection with the Open Offer made to the public shareholders of the Company.

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+9.2%1-day move
₹402.40
prior close
₹434.95
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.7-0.1-0.5-0.4+9.2+12.7+8.8+4.7+4.7+8.8+16.7+30.6
Up moveDown movePending
AI summary

SBI Capital Markets Limited, acting as the manager to an Open Offer, has submitted a copy of a newspaper publication containing the Detailed Public Statement to the Exchange. This is a mandatory regulatory disclosure under SEBI's Takeover Regulations, typically triggered when an acquirer crosses a certain ownership threshold in the company. The publication in newspapers serves to formally inform public shareholders about the Open Offer price, quantity, and timeline for tendering their shares. This filing confirms compliance with disclosure norms but does not itself contain the offer price or size details.

Likely market impact

For shareholders, this signals that an Open Offer event is underway or imminent — investors should look out for the detailed offer terms (price, size, and acceptance window) in the published notice. Such events often lead to short-term price movements as the market prices in the offer premium and potential deal outcome.